Clinical Trial Update: Study to Evaluate MET642 in Patients With NASH [Phase 2]

View source ↗

Summary

Phase 2 trial update for MET642 in nonalcoholic steatohepatitis (NASH) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• MET642

Snippet

Sponsor: Metacrine, Inc. | Conditions: NASH - Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED